Literature DB >> 2582148

Regulation of Moloney murine leukemia virus replication in chronically infected cells arrested at the G0/G1 phase.

I Gloger, G Arad, A Panet.   

Abstract

The replication of Moloney murine leukemia virus (MMuLV) in chronically infected mouse cells arrested at the G0/G1 phase of the cell cycle by different procedures was investigated. MMuLV production was inhibited in glutamine- and isoleucine (Gln-Ile)-deprived G0/G1 cells. In contrast, butyric acid treatment, which efficiently arrested the cells at the G0/G1 phase of the cell cycle, did not inhibit MMuLV production. Furthermore, the inhibition of MMuLV production caused by either Gln-Ile deprivation or by interferon (IFN) treatment was overcome by butyric acid treatment. Thus, the replication of MMuLV could be dissociated from cell proliferation. The inhibition of MMuLV production in Gln-Ile-deprived cell cultures was compared to the inhibitory effect of IFN, which is known to affect budding and release of the virus. Rates of MMuLV protein synthesis were not affected in both the IFN-treated and Gln-Ile-deprived cells. However, processing of the viral polyprotein Pre65gag into p30 was blocked in the Gln-Ile-deprived cells. Furthermore, whereas in IFN-treated cells, MMuLV accumulated on the cell surface and could be released upon treatment with trypsin, in Gln-Ile-deprived cells, no virions were released by such treatment. These results indicate that in cells arrested by Gln-Ile deprivation, MMuLV is inhibited at a posttranslation step. This step appears to precede the anti-MMuLV block induced by IFN.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582148      PMCID: PMC254872     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Dependence of Moloney murine leukemia virus production on cell growth.

Authors:  M P Paskind; R A Weinberg; D Baltimore
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Transformation by a temperature sensitive mutant of Rous sarcoma virus in the absence of serum.

Authors:  J G Bell; J A Wyke; I A Macpherson
Journal:  J Gen Virol       Date:  1975-05       Impact factor: 3.891

3.  Synchronization of Rous sarcoma virus production in chick embryo cells.

Authors:  J A Leong; W Levinson; M J Bishop
Journal:  Virology       Date:  1972-01       Impact factor: 3.616

4.  Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon.

Authors:  R M Friedman; J M Ramseur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

5.  A restriction point for control of normal animal cell proliferation.

Authors:  A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

6.  RNA metabolism of murine leukemia virus: detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA.

Authors:  H Fan; D Baltimore
Journal:  J Mol Biol       Date:  1973-10-15       Impact factor: 5.469

7.  Translation of murine leukemia virus RNA in cell-free systems from animal cells.

Authors:  I M Kerr; U Olshevsky; H F Lodish; D Baltimore
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

8.  Relationship of Friend murine leukemia virus production to growth and hemoglobin synthesis in cultured erythroleukemia cells.

Authors:  C C Sherton; L H Evans; E Polonoff; D Kabat
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

9.  Requirement for cell division for initiation of transcription of Rous sarcoma virus RNA.

Authors:  E H Humphries; H M Temin
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

10.  Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure.

Authors:  J G Levin; S C Hu; A Rein; L I Messer; B I Gerwin
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more
  2 in total

1.  Development of a laboratory scalable process for enhancing lentivirus production by transient transfection of HEK293 adherent cultures.

Authors:  Y K Ho; H P Too
Journal:  Gene Ther       Date:  2020-04-27       Impact factor: 5.250

2.  Inhibition in vitro of the replication of murine cytomegalovirus or reovirus type 3 by the glutamine analogue acivicin.

Authors:  D Keast; A R Vasquez
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.